High-Quality Linaclotide CAS 851199-59-2: China Suppliers and Factory for IBS-C and CIC Treatment Solutions Manufacturer, Manufacturers
Linaclotide is a prescription medication approved for the effective treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Manufactured in high-quality factories, this medication functions by enhancing intestinal fluid secretion, which helps soften stool and encourages regular bowel movements. By promoting bowel regularity, Linaclotide alleviates discomfort associated with constipation, including bloating, abdominal pain, and straining during bowel movements. As a trusted product among suppliers in China, Linaclotide offers a reliable solution for those suffering from chronic constipation issues
Linaclotide is a prescription medicine that has been clinically proven to be effective in treating irritable bowel syndrome (IBS-C) and chronic enteroendocrine syndrome (CIC). Its mechanism of action is to increase intestinal fluid secretion, thereby softening stool and promoting regular bowel movements. This mechanism of action not only promotes bowel movements, but also relieves the discomfort caused by constipation, such as bloating, abdominal pain and straining during bowel movements.
Mechanism & Efficacy
Linaclotide is a guanylate cyclase-C agonist that enhances intestinal fluid secretion and accelerates transit, commonly used in research on chronic constipation and irritable bowel syndrome with constipation (IBS-C).
Dosage & Research Use
Linaclotide, approved clinically for chronic idiopathic constipation and IBS‑C, typically comes in microgram doses (e.g., 72 mcg, 145 mcg, 290 mcg capsules in clinical settings). Research applications should reflect standard mg‑to‑mcg scaling and follow rigorous protocols. (Note: This product is intended for research and not for direct clinical application.)
Frequently Asked Questions
QWhat is Linaclotide clinically used to treat?
Linaclotide is clinically proven to be effective in treating irritable bowel syndrome with constipation (IBS-C) and chronic enteroendocrine syndrome (CIC).
QHow does Linaclotide relieve constipation?
It increases intestinal fluid secretion, which softens the stool and promotes regular bowel movements, thereby relieving bloating, abdominal pain, and straining.
QWhat is the exact mechanism of action?
It acts as a guanylate cyclase-C agonist, enhancing intestinal fluid secretion and significantly accelerating intestinal transit time.
QWhat are the typical clinical dosages available?
In clinical settings, Linaclotide typically comes in microgram doses, such as 72 mcg, 145 mcg, and 290 mcg capsules.
QCan this specific product be used for direct clinical application?
No, this product is intended strictly for research purposes and must follow rigorous research protocols. It is not for direct clinical application.
Thin
